Redox regulation in metabolic programming and inflammation.

Current understanding of immune cell function emphasizes the role of metabolic pathways in determining inflammatory outcomes. Prior research has shown that immune responses require rapid energy availability, particularly for processes like migration and reactive oxygen species production. Neutrophils, as first responders, rely heavily on glycolysis to fuel their short-lived inflammatory activity. Monocytes later take over, transitioning into M2 macrophages to resolve inflammation. It was already known that corticosteroids can shift macrophage metabolism from glycolysis to oxidative phosphorylation. However, the precise mechanisms linking redox state and metabolic reprogramming remain unclear. This gap motivated recent investigations into how redox regulation influences macrophage polarization and inflammation resolution. No prior work had resolved how NOX2 activation and CD36 signaling coordinate metabolic shifts. Understanding these processes could clarify how immune cells adapt their energy use during inflammation.

This study aimed to clarify the metabolic and redox mechanisms that govern macrophage function during inflammation. The specific problem addressed is how immune cells transition from proinflammatory to anti-inflammatory states. The motivation stems from the need to understand how energy metabolism and redox signaling interact to regulate immune responses. Neutrophils and monocytes represent distinct metabolic profiles, with neutrophils relying on glycolysis and monocytes switching to oxidative phosphorylation. The study sought to determine how NOX2 activation and CD36 signaling influence these transitions. By examining the role of NADPH, glucose transporters, and mitochondrial efficiency, the researchers aimed to identify key metabolic checkpoints. The goal was to provide a mechanistic framework for how redox regulation shapes immune cell behavior. This work could inform strategies to modulate inflammation through metabolic control.

The researchers reviewed existing literature on immune cell metabolism and redox signaling. They focused on how neutrophils and macrophages use glycolysis and oxidative phosphorylation during inflammation. The study analyzed how NOX2 activation affects glucose transporter trafficking and glucose uptake. The team also examined the role of CD36 in resolving inflammation through interactions with apoptotic membranes. They evaluated how AMPK and PPARγ activation influences mitochondrial biogenesis and arginase expression. The approach included comparing M1 and M2 macrophage metabolic profiles. The researchers traced how corticosteroids induce anti-inflammatory shifts in macrophage metabolism. The study synthesized evidence from prior experiments on NOX2, CD36, and mitochondrial function.

The strongest finding is that M2 macrophages rely on oxidative phosphorylation rather than glycolysis. NOX2 activation increases glucose uptake by promoting glucose transporter trafficking. Mitochondrial efficiency is likely reduced in M1 macrophages due to nitrosylation of the electron transport chain. CD36 signaling triggers AMPK and PPARγ activation, promoting mitochondrial biogenesis. M2 macrophages produce fewer proinflammatory cytokines but maintain anti-inflammatory growth factors. The study found that CD36 interacts with oxidized phosphatidylserine on apoptotic membranes. This interaction initiates the resolution phase of inflammation. The results suggest that metabolic reprogramming is essential for macrophage function during inflammation.

The authors propose that redox regulation and metabolic reprogramming are tightly linked in immune cell function. They suggest that NOX2 activation supports M1 macrophage polarization by increasing glucose uptake. The study concludes that CD36 signaling is crucial for resolving inflammation through mitochondrial biogenesis. The findings indicate that M2 macrophages maintain anti-inflammatory activity while reducing proinflammatory cytokine production. The authors state that corticosteroids induce a metabolic shift from glycolysis to oxidative phosphorylation. They propose that mitochondrial efficiency is compromised in M1 macrophages. The study concludes that redox signaling influences immune cell metabolism during inflammation. The authors suggest that these mechanisms could be targeted to modulate inflammatory responses.